Oslo, Norway, March 8, 2024 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics ASA, has today acquired 40,000 shares in Nykode Therapeutics ASA at an average price of NOK 13.81 per share. Following the transaction, Martin Nicklasson holds 92,000 shares in Nykode Therapeutics ASA. 
 
Please see further details in the attached document.